Relief for pharma cos as Delhi HC says cough syrup ban applies prospectively
New Delhi: In a relief to pharma companies, including Glenmark Pharmaceuticals and Zuventus Healthcare, the Delhi High Court on Thursday held that the government’s April 15 notification that prohibited the…
Glenmark Pharmaceuticals acquires and launches acetylcysteine injection
Glenmark Pharmaceuticals USA announces the acquisition and launch of Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) single-dose vials. Glenmark’s Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) single-dose vials can be…
Glenmark Pharma’s US arm launches Latanoprost’s bioequivalent solution
Glenmark Pharmaceuticals said that US-based Glenmark Pharmaceuticals Inc. has launched Latanoprost Ophthalmic Solution. The aforementioned solution is bioequivalent and therapeutically equivalent to the reference listed drug Xalatan Ophthalmic Solution of…
Glenmark secures MHRA approval to launch Winlevi in the UK
Glenmark Pharmaceuticals (Glenmark) has received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to market Winlevi in the United Kingdom. The topical treatment for acne vulgaris is approved…
Glenmark Pharma share rises 2% as unit launches blood clotting drug
Glenmark Pharmaceuticals share price:Pharmaceutical major Glenmark Pharmaceuticals shares rose up to 2.23 per cent to hit an intraday high of Rs 1,537.90 per share on Tuesday, January 21, 2025. The…
Glenmark inks pact with Menarini Group to commercialise nasal spray in Europe
NEW DELHI: Glenmark Pharmaceuticals on Wednesday said its subsidiary has inked a licensing pact with Menarini Group for commercialising its nasal spray Ryaltris across 33 countries in Europe, including the Balkan region. Glenmark Specialty, a Switzerland-based unit…
Threat to Indian pharmaceutical company, may cost more than 6 thousand crores in the US
A total of 44 US states on Monday filed a lawsuit against as many as 20 generic drug manufacturers, including seven Indian firms. Among these Indian firms, 5 have been…
Price War In Anti Diabetic Medicine Segment
A price war is brewing in India’s growing diabetes drug market, drawing comparisons with the recent tariff battles in the telecom sector. Glenmark Pharmaceuticals NSE -1.45 % has launched a patented…
